Primary Amyloidosis Disease Description

Amyloidosis is a disease characterized by extracellular accumulation of fibrils in various organs of the body. The precursor protein can be varied, but it all contains an antiparallel beta sheet flake arrangement so that when stained with Congo red produces amyloidogenic properties and a unique response (green birefringence under polarization). All kinds of amyloid consist of members of serum amyloid P component, 25-kD glycoprotein, and C-reactive protein containing pentamer protein family.

Transthyretin amyloidosis (TA) is a genetic mutation in the TTR gene that directs the body to produce a protein called transthyretin. This protein plays a major role in the transport of hormones called retinol (vitamin A) and thyroxine in the liver. Mutation of the TTR gene is thought to alter the structure of this protein, allow the protein to deposit on the peripheral nervous system, and alter the ability of the body to detect tactile, painful, fever, and sound sensations I will. It also affects the central nervous system (brain and spinal cord), heart, kidney and gastrointestinal tract. It is a dominant gene and means that you only need a parent with a disease to get it. Make it highly genetic

Tay sax disease is a hereditary disease of the fatal central nervous system, and it is a recessive gene. The central nervous system includes brain, brain coverage, and spinal cord. The most common illness will develop in infants. Infants with Tay-Sachs disease are deficient in hexosaminidase A, an enzyme necessary for degrading certain fatty substances in the brain and nerve cells. These fatty acids accumulate in the brain, causing neurological deterioration. Infected infants appear to be healthy at birth and appear to grow normally during the first few months of life. The destructive process starts from the first semester of pregnancy

Transthyretin amyloidosis patients with fatal hereditary diseases experience progressive pain, weakness and ultimate organ failure. However, many patients did not receive a diagnosis within several years after onset of symptoms. Currently, researchers show that at a typical neurologist's visit, a rapid invasive skin biopsy can visually indicate the characteristic protein mass of the disease.